Molbio Diagnostics Ltd (MOLBIO) — Announcement | 2 September 2026

· BSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Company schedules earnings conference call for September 8, 2026
💡 Investor Takeaway
Investors can attend the call to hear management discuss quarterly results and outlook.

Molbio Diagnostics announced an earnings conference call on September 8, 2026 at 4:00 PM IST to discuss Q1 FY27 results for the quarter ended June 30, 2026, inviting investors and analysts to review financial performance and future outlook.

📄 View Original Announcement (PDF)

About Molbio Diagnostics Ltd (MOLBIO)

Healthcare · Healthcare · Listed on BSE

Market Cap: ₹16,255.48 Cr

View full MOLBIO stock details →

📡 Get AI alerts when MOLBIO files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track MOLBIO — Free

📊 More MOLBIO filings

See all MOLBIO filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when MOLBIO files new disclosures

Track MOLBIO filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track MOLBIO — Free

Free account · 2 AI queries/day